Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Susana Banerjee

Reader in Women's Cancers (Systemic Therapy and Clinical Trials)

Institute of Cancer Research

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Obstetrics And Gynecology

40%

Pharmacotherapy

80%

Oncology

80%

Ovarian Cancer

50%

Cancer Therapy

50%

Cancer Biology

50%

Gynecologic Oncology

50%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Predicting treatment benefit in low grade serous ovarian cancer (LGSOC) - tumour and liquid biopsy mutation analysis

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Supporting oncology patients on maintenance therapies with blood test monitoring

Open Date: 2020-01-01

Close Date:

Grant: Close

Affinity: Home blood count monitoring for personalised delivery of cancer therapy

Open Date: 2019-02-01

Close Date: 2021-07-30

Grant: Close

A phase II study of the anti-PD-L1 antibody atezolizumab, bevacizumab and acetylsalicylic acid to investigate safety and efficacy of this combination in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma

Open Date: 2019-01-01

Close Date: 2019-12-31

Grant: Close

Using Genetics in Mainstream Medicine to Deliver Personalised Care for Cancer Patients.

Open Date: 2012-10-01

Close Date: 2018-03-31

Articles14

Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02

Article Link

Year:

2024

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Article Link

Year:

2024

Top advances of the year: Immunotherapy in endometrial cancer

Article Link

Year:

2024

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Article Link

Year:

2023

Low-grade serous ovarian cancer: expert consensus report on the state of the science

Article Link

Year:

2023

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Article Link

Year:

2023

New therapies for clear cell ovarian carcinoma

Article Link

Year:

2023

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

Article Link

Year:

2023

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10

Article Link

Year:

2023

The peritoneal cancer index as a predictor of complete cytoreduction at primary and interval cytoreductive surgery in advanced ovarian cancer

Article Link

Year:

2023

A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

Article Link

Year:

2022

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data

Article Link

Year:

2022

Describing Unmet Supportive Care Needs among Young Adults with Cancer (25–39 Years) and the Relationship with Health-Related Quality of Life, Psychological Distress, and Illness Cognitions

Article Link

Year:

2021

Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers

Article Link

Year:

2021

Collaborators9

Dearbhaile Collins

Senior Lecturer in Cancer Research

University College Cork

IRELAND

Rebecca S. Kristeleit

University of Arizona College of Medicine

UNITED STATES

ANA OAKNIN

Head of Gynecological Cancer Program

Hospital Universitari Vall d'Hebron

SPAIN

Cara Mathews

Assistant Professor

UNITED STATES

rebecca arend

Assistant Professor

The University of Alabama

UNITED STATES

Mansoor Mirza

Chief Oncologist

Rigshospitalet

DENMARK

Kwong-Kwok Wong

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Robert L. Coleman

UNITED STATES

Stephanie Gaillard

Johns Hopkins University

UNITED STATES

How do I reach out?

Meet Kite AI